India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
EXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS Why in the News? Clinical Trial: The Democratic Republic of Congo (DRC) has launched a clinical trial to evaluate Gilead Sciences’ experimental antiviral drug Obeldesivir as a post-exposure treatment for the ongoing Bundibugyo Ebola virus outbreak in Congo and Uganda. Research Initiative: The study seeks to determine whether …
Read MoreKERALA’S CRUDE BIRTH RATE FALLS BELOW 10 FOR THE FIRST TIME Why in the News? Historic Demographic Shift: Kerala’s Vital Statistics Report 2024 shows that the Crude Birth Rate (CBR) has fallen below 10 for the first time, indicating an advanced stage of demographic transition with implications for regional economic integration and workforce planning. Population …
Read MoreSTUDY TO CONTAIN ANTIMICROBIAL-RESISTANT NEONATAL SEPSIS BEGINS IN INDIA Why in the News? India Joins Global Trial: India has joined the NeoSep1 international clinical trial to evaluate effective antibiotic combinations for antimicrobial-resistant neonatal sepsis, with the first participants enrolled at JIPMER, Puducherry and PGIMS, Rohtak, demonstrating strategic alignment with global health priorities. Public Health Significance: …
Read MoreCOUNTRIES RESUME TALKS TO FINALISE WHO PANDEMIC TREATY Why in the News? PABS Negotiations: WHO member states have resumed negotiations in Geneva to finalise the Pathogen Access and Benefit-Sharing (PABS) mechanism under the Pandemic Agreement through enhanced diplomatic engagement and multilateral engagement. Fresh Urgency: The ongoing Ebola outbreak in the Democratic Republic of the Congo …
Read MoreWHO FLAGS GROWING INEQUITIES IN GLOBAL CANCER CARE Why in the News? WHO Report Released: The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) released the Global Status Report on Cancer, 2026, highlighting widening inequalities in cancer prevention, diagnosis, treatment, and survival amid growing strategic competition in global healthcare systems. …
Read MoreAIR POLLUTION PLAN NEEDS POLITICAL WILL, NOT AN EYE ON THE ELECTION CYCLE Syllabus: GS2: Issues related to development and management of social sector Health Why in the News? The Delhi Government’s Electric Vehicle (EV) Policy 2.0 seeks to accelerate the transition towards electric mobility by phasing out registrations of conventional vehicles. While the initiative …
Read MoreA SHOT AT LIFE, MANDSAUR’S MODEL FOR HPV VACCINATION Syllabus: GS2: Issues related to development and management of social sector Health Why in the News? The Government of India launched a nationwide HPV vaccination campaign on February 28, 2026, providing free vaccines to girls aged 14–15 years. Mandsaur district in Madhya Pradesh achieved 100% vaccination …
Read MoreFrance’s Heatwave Deaths: A Warning for the World Syllabus Linkage: GS Paper I: Geography and climate; GS Paper II: Governance and health; GS Paper III: Disaster management, environment and climate change; Essay Article Type: UPSC Rapid Revision Article | 360-degree Mains Analysis | Prelims Facts + Mains Dimensions 1. Why in News? France has recorded …
Read MoreBrazil Dengue Vaccine Deaths Trigger Safety Concerns Why in the News ? The suspension of Brazil’s Butantan-DV dengue vaccine after reports of severe adverse events and two deaths has raised concerns about the safety of India’s upcoming DengiAll vaccine, as both are based on similar vaccine technology. This development highlights the importance of the precautionary …
Read MoreINDIA NEEDS INNOVATIVE STRATEGIES TO ELIMINATE TB Syllabus: GS 2: Issues related to the Social sector : Health care. Government policies and interventions. Why in the News? India’s fight against Tuberculosis (TB) has gained momentum following encouraging results from the PreVenTB Trial, which demonstrated significant efficacy of indigenous vaccines against extrapulmonary TB. The findings …
Read More
